Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Is it common for a pharma deal for one compound (Bril) to include an equity stake, particularly when you have several compounds under development? (CTIX is not a one-trick pony.) Such a deal would be prelude to a broad strategic partnership with the possibility of eventual (5 or 10 years) full acquisition.

And the verbiage of the shelf wasn't consistent with a pharma deal equity component.

I expect very soon either we get an explanation from management or the next shoe drops.